Dogmas, challenges, and promises in phase III allergen immunotherapy studies

by Pieter-Jan De Kam, PhD, Matthias F. Kramer, MD, Mohamed H. Shamji, PhD, Kemi Oluwayi, MD, Matthew D. Heath, PhD, Erika Jensen-Jarolim, MD, Markus H. Berger, MD, Uwe E. Berger, MBA, Anke Graessel, PhD, Fiona Sellwood, Stefan Zielen, MD, Christian Vogelberg, MD, Petra Zieglmayer, MD, Ralph Mösges, MD, PhD, Ludger Klimek, MD, PhD, Lawrence M. DuBuske, MD, Wayne G. Shreffler, MD, PhD, Jonathan A. Bernstein, MD, Thomas M. Kündig, MD, Murray A. Skinner, PhD
Published 2021-09-01